Merck
MRK
#38
Rank
C$515.45 B
Marketcap
C$208.92
Share price
2.18%
Change (1 day)
73.44%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$1.72

According to Merck's latest financial reports the company's current EPS (TTM) is C$1.77. In 2025 the company made an earnings per share (EPS) of C$10.21 an increase over its 2024 EPS that were of C$9.44.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.72-83.13%
2025C$10.218.15%
2024C$9.444308.46%
2023C$0.21-97.32%
2022C$8.0110.92%
2021C$7.2284.68%
2020C$3.91-27.2%
2019C$5.3763.44%
2018C$3.28151.11%
2017C$1.31-54.58%
2016C$2.8830.21%
2015C$2.21-61.99%
2014C$5.82180.51%
2013C$2.07-31.82%
2012C$3.046.62%
2011C$2.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.20 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.31 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.06-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$4.36 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$41.76 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$22.66 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.66 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.34 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.47 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.88-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel